Κατηγορία: Ειδήσεις
Τα προκαταρκτικά αποτελέσματα ερευνών δείχνουν ότι η ψιλοκυβίνη, το ενεργό συστατικό στα «μαγικά» μανιτάρια, μπορεί ενδεχομένως να βοηθήσει τους καπνιστές ώστε να ξεπεράσουν τον εθισμό στη νικοτίνη, όταν η ψιλοκυβίνη χορηγείται σε συνδυασμό με γνωσιακή-συμπεριφορική θεραπεία.
For more than 40 years, Charlie Bessant was that guy.
The guy who'd slink out of every party to catch a smoke on the sly. Who'd walk for blocks late at night through his dicey DC neighborhood to score a pack of Marlboro Lights, no matter the weather.
Bessant tried and failed to quit many times. He used the nicotine patch, gum—you name it.
“I always thought, ‘I'm going to quit—this is my last pack,’ ” says Bessant, 64, now living in Silver Spring and semiretired from his work making mounts for museum exhibits. “A big percentage of packs I bought were the last pack I ever bought.”
But on a fall day in 2009, Bessant walked into a building at Johns Hopkins Bayview Medical Center in Baltimore. In Room 3102, he was given a dark-blue capsule to swallow. He lay down on a couch and nestled inside a cocoon of blankets. He put on eyeshades and headphones and waited for the blue capsule to do its thing.
And he never smoked another cigarette again.
Τα προκαταρκτικά αποτελέσματα ερευνών δείχνουν ότι η ψιλοκυβίνη, το ενεργό συστατικό στα «μαγικά» μανιτάρια, μπορεί ενδεχομένως να βοηθήσει τους καπνιστές ώστε να ξεπεράσουν τον εθισμό στη νικοτίνη, όταν η ψιλοκυβίνη χορηγείται σε συνδυασμό με γνωσιακή-συμπεριφορική θεραπεία.
For more than 40 years, Charlie Bessant was that guy.
The guy who'd slink out of every party to catch a smoke on the sly. Who'd walk for blocks late at night through his dicey DC neighborhood to score a pack of Marlboro Lights, no matter the weather.
Bessant tried and failed to quit many times. He used the nicotine patch, gum—you name it.
“I always thought, ‘I'm going to quit—this is my last pack,’ ” says Bessant, 64, now living in Silver Spring and semiretired from his work making mounts for museum exhibits. “A big percentage of packs I bought were the last pack I ever bought.”
But on a fall day in 2009, Bessant walked into a building at Johns Hopkins Bayview Medical Center in Baltimore. In Room 3102, he was given a dark-blue capsule to swallow. He lay down on a couch and nestled inside a cocoon of blankets. He put on eyeshades and headphones and waited for the blue capsule to do its thing.
And he never smoked another cigarette again.
